Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Arthritis Rheumatol
; 73(1): 121-131, 2021 01.
Article
in En
| MEDLINE
| ID: mdl-32755035
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lupus Nephritis
/
Cyclophosphamide
/
Antibodies, Monoclonal, Humanized
/
Rituximab
/
Immunosuppressive Agents
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Arthritis Rheumatol
Year:
2021
Document type:
Article
Country of publication:
United States